These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7359313)

  • 1. Preparation and biological actions of N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine.
    O'Donnell JP; Azzaro AJ; Urquilla PR
    J Pharm Sci; 1980 Feb; 69(2):149-52. PubMed ID: 7359313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 3. The dopamine-sensitive adenylate cyclase of the rat caudate nucleus--3. The effect of aporphines and protoberberines.
    Sheppard H; Brughardt CR
    Biochem Pharmacol; 1978; 27(8):1113-6. PubMed ID: 697912
    [No Abstract]   [Full Text] [Related]  

  • 4. (3,4-Dihydroxybenzyl)-2-imidazoline (DHBI): an analogue of dopamine.
    O'Donnell JP; Azzaro AJ; Urquilla PR
    Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):243-51. PubMed ID: 230552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rigid analogues of dopamine: synthesis and interaction of 6-exo- and 6-endo-(3',4'-dihydroxyphenyl)-2-azabicyclo[2.2.2]octanes with dopamine uptake sites and receptors.
    Law SJ; Morgan JM; Masten LW; Borne RF; Arana GW; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Mar; 25(3):213-6. PubMed ID: 7069700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron inhibits D-1 dopamine receptor coupled adenylate cyclase via G-proteins in the caudate nucleus of the rat.
    Moser A; Schuster O
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1372-7. PubMed ID: 1699528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL; Wilson JW; Hieble JP
    J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
    Massingham R; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives.
    Kaiser C; Dandridge PA; Garvey E; Flaim KE; Zeid RL; Hieble JP
    J Med Chem; 1985 Dec; 28(12):1803-10. PubMed ID: 4068005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine.
    Woodruff GN; Watling KJ; Andrews CD; Poat JA; McDermed JD
    J Pharm Pharmacol; 1977 Jul; 29(7):422-7. PubMed ID: 19581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.
    Izenwasser S; Katz JL
    Eur J Pharmacol; 1993 Jun; 246(1):39-44. PubMed ID: 8102607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological characterization of 2-(4-chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Abbracchio MP; Paoletti AM; Balduini W
    J Med Chem; 1992 Nov; 35(23):4408-14. PubMed ID: 1360027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
    Schoffelmeer AN; Rice KC; Heijna MH; Hogenboom F; Mulder AH
    Eur J Pharmacol; 1988 Apr; 149(1-2):179-82. PubMed ID: 2840299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.
    Cannon JG; Hsu FL; Long JP; Flynn JR; Costall B; Naylor RJ
    J Med Chem; 1978 Mar; 21(3):248-53. PubMed ID: 564406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease.
    Shibuya M
    J Neural Transm; 1979; 44(4):287-95. PubMed ID: 458431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.
    Anderson K; Kuruvilla A; Uretsky N; Miller DD
    J Med Chem; 1981 Jun; 24(6):683-7. PubMed ID: 7252978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine inhibition of anterior pituitary adenylate cyclase is mediated through the high-affinity state of the D2 receptor.
    Borgundvaag B; George SR
    Life Sci; 1985 Jul; 37(4):379-86. PubMed ID: 4040201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
    Unterwald EM; Cox BM; Kreek MJ; Cote TE; Izenwasser S
    Synapse; 1993 Sep; 15(1):33-8. PubMed ID: 8310423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
    Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
    Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.